β-Catenin/LEF-1 Signalling in Breast Cancer – Central Players Activated by a Plethora of Inputs

Publisher： Karger

E-ISSN： 1422-6421|185|1-3|51-60

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.185, Iss.1-3, 2007-06, pp. : 51-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wnt/&bgr;-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 716-727

Bentham Science Publishers

Access to resources Recommend Favorite

A Wnt-ow of Opportunity: Targeting the Wnt/&bgr;-Catenin Pathway in Breast Cancer

By  

Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. : 1074-1088

Bentham Science Publishers

Access to resources Recommend Favorite

Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 4, 2018-04 ,pp. : 390-399

Bentham Science Publishers

Access to resources Recommend Favorite

The potential of targeting Wnt/β-catenin in colon cancer

By Sebio Ana   Kahn Michael   Lenz Heinz-Josef  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 611-615

Informa Healthcare

Access to resources Recommend Favorite

Integrin α3β1 as a breast cancer target

By Subbaram Sita   DiPersio C Michael  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. : 1197-1210

Informa Healthcare

Access to resources Recommend Favorite